Shoppers Drug Mart Corp (SC.TO)

BUY
Still haven't tapped the full earnings potential. Should show 15/20% growth annually over the next couple of years.
TOP PICK
A growth story. Have been growing earnings 23/24% a year since going public. Should continue. Expects a dividend to be forthcoming.
BUY
Management has been good at delivering cost savings. Looking at this stock as a possible purchase.
BUY
Currently looking at it. A great company. The new strategy of focusing on cosmetics and beauty products is very positive. Great demographic play.
WEAK BUY
A more intriguing name is Jean Coutu Group which has a whole new growth potential with their purchase of Eckerd drugs in the US.
TOP PICK
Try to buy under $31. Growing at Strong double digits. Well positioned in the convenience markets.
BUY
Good-quality. A long-term hold.
BUY ON WEAKNESS
A very well-run business with a great management team. Valuation is getting a little stretched. Would buy under $30.
BUY
Very solid company. Should continue to do reasonably well over the next 12 months.
BUY ON WEAKNESS
A good company. A little bit expensive, but would buy on any pullback.
BUY ON WEAKNESS
Careful about the retail sector, but this is one company they like. Doing a good job and are very competitive. May be getting a little stretched in valuation.
BUY
Has done a fabulous job of increasing its market share by expanding its cosmetics.
PAST TOP PICK
(A top pick Dec 12/03. Up 14%.) Still likes, but wouldn't buy more at this price. Sees good opportunities for growth going forward.
WEAK BUY
Own and like. Leading drug store chain. Going to keep on selling stocks. Making lots of gains. Paying 25x earnings
BUY
Demographics are wonderful for drugs. Have done a very good job of selling front of store cosmetics.
Showing 361 to 375 of 452 entries